Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119281626 | 11928162 | 6 | F | 200110 | 20160920 | 20160119 | 20160927 | EXP | GB-VIIV HEALTHCARE LIMITED-GB2016004187 | VIIV | 0.00 | N | M | Y | 2.50000 | KG | 20160927 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119281626 | 11928162 | 1 | PS | Abacavir sulphate | ABACAVIR | 1 | Transplacental | 300 MG, BID | U | 20977 | 300 | MG | BID | ||||||
| 119281626 | 11928162 | 2 | SS | ZIDOVUDINE. | ZIDOVUDINE | 1 | Transplacental | 250 MG, BID | 76500 | MG | U | 0 | 250 | MG | BID | ||||
| 119281626 | 11928162 | 3 | SS | VIRAMUNE | NEVIRAPINE | 1 | Transplacental | 200 MG, QD | U | 0 | 200 | MG | QD | ||||||
| 119281626 | 11928162 | 4 | SS | VIDEX | DIDANOSINE | 1 | Transplacental | 200 MG, BID | U | 0 | 200 | MG | BID | ||||||
| 119281626 | 11928162 | 5 | SS | ZERIT | STAVUDINE | 1 | Transplacental | 40 MG, BID | U | 0 | 40 | MG | BID | ||||||
| 119281626 | 11928162 | 6 | C | Septrin | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Transplacental | UNK, QD | U | 0 | |||||||||
| 119281626 | 11928162 | 7 | C | FOLIC ACID. | FOLIC ACID | 1 | Transplacental | 1 DF, QD | U | 0 | 1 | DF | TABLET | QD | |||||
| 119281626 | 11928162 | 8 | C | ANHYDROUS FERROUS SULPHATE | 2 | Transplacental | 1 DF, QD | U | 0 | 1 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119281626 | 11928162 | 1 | HIV infection |
| 119281626 | 11928162 | 2 | HIV infection |
| 119281626 | 11928162 | 3 | HIV infection |
| 119281626 | 11928162 | 4 | HIV infection |
| 119281626 | 11928162 | 5 | HIV infection |
| 119281626 | 11928162 | 6 | Product used for unknown indication |
| 119281626 | 11928162 | 7 | Product used for unknown indication |
| 119281626 | 11928162 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119281626 | 11928162 | OT |
| 119281626 | 11928162 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119281626 | 11928162 | Blood insulin increased | |
| 119281626 | 11928162 | Foetal distress syndrome | |
| 119281626 | 11928162 | Foetal exposure during pregnancy | |
| 119281626 | 11928162 | Hypoglycaemia neonatal | |
| 119281626 | 11928162 | Nervous system disorder | |
| 119281626 | 11928162 | Small for dates baby |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119281626 | 11928162 | 1 | 200103 | 0 | ||
| 119281626 | 11928162 | 2 | 20010501 | 20011022 | 0 | |
| 119281626 | 11928162 | 3 | 199906 | 0 | ||
| 119281626 | 11928162 | 4 | 199906 | 0 | ||
| 119281626 | 11928162 | 5 | 199706 | 200104 | 0 |